 | • レポートコード：QYR2104Z3172 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、吸入・点鼻薬ジェネリック医薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、気管支拡張薬、抗ヒスタミン薬、うっ血性スプレー、その他）、用途別市場規模（喘息、慢性閉塞性肺疾患（COPD）、アレルギー性鼻炎、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・吸入・点鼻薬ジェネリック医薬品の市場動向 ・企業の競争状況、市場シェア ・吸入・点鼻薬ジェネリック医薬品の種類別市場規模（コルチコステロイド、気管支拡張薬、抗ヒスタミン薬、うっ血性スプレー、その他） ・吸入・点鼻薬ジェネリック医薬品の用途別市場規模（喘息、慢性閉塞性肺疾患（COPD）、アレルギー性鼻炎、その他） ・吸入・点鼻薬ジェネリック医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・吸入・点鼻薬ジェネリック医薬品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・吸入・点鼻薬ジェネリック医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・吸入・点鼻薬ジェネリック医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・吸入・点鼻薬ジェネリック医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Beximco Pharmaceuticals Ltd、Cipla Limited、Mylan N.V.、Nephron Pharmaceuticals Corporation、Sun Pharmaceutical Industries Ltd.、Hikma Pharmaceuticals、Novartis、Perrigo Company、Catalent Pharma Solutions、Teva Pharmaceutical Industries Ltd.） ・結論 |
Market Analysis and Insights: Global Inhalation and Nasal Sprays Generic Drugs Market
The global Inhalation and Nasal Sprays Generic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Inhalation and Nasal Sprays Generic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Inhalation and Nasal Sprays Generic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Inhalation and Nasal Sprays Generic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Inhalation and Nasal Sprays Generic Drugs market.
Global Inhalation and Nasal Sprays Generic Drugs Scope and Market Size
Inhalation and Nasal Sprays Generic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Inhalation and Nasal Sprays Generic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Corticosteroids
Bronchodilator
Antihistamine
Congestive Spray
Other
Segment by Application
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Allergic Rhinitis
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Beximco Pharmaceuticals Ltd
Cipla Limited
Mylan N.V.
Nephron Pharmaceuticals Corporation
Sun Pharmaceutical Industries Ltd.
Hikma Pharmaceuticals
Novartis
Perrigo Company
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inhalation and Nasal Sprays Generic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Bronchodilator
1.2.4 Antihistamine
1.2.5 Congestive Spray
1.2.6 Other
1.3 Market by Application
1.3.1 Global Inhalation and Nasal Sprays Generic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Asthma
1.3.3 Chronic Obstructive Pulmonary Disease (COPD)
1.3.4 Allergic Rhinitis
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Inhalation and Nasal Sprays Generic Drugs Market Perspective (2016-2027)
2.2 Inhalation and Nasal Sprays Generic Drugs Growth Trends by Regions
2.2.1 Inhalation and Nasal Sprays Generic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Inhalation and Nasal Sprays Generic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Inhalation and Nasal Sprays Generic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Inhalation and Nasal Sprays Generic Drugs Industry Dynamic
2.3.1 Inhalation and Nasal Sprays Generic Drugs Market Trends
2.3.2 Inhalation and Nasal Sprays Generic Drugs Market Drivers
2.3.3 Inhalation and Nasal Sprays Generic Drugs Market Challenges
2.3.4 Inhalation and Nasal Sprays Generic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inhalation and Nasal Sprays Generic Drugs Players by Revenue
3.1.1 Global Top Inhalation and Nasal Sprays Generic Drugs Players by Revenue (2016-2021)
3.1.2 Global Inhalation and Nasal Sprays Generic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Inhalation and Nasal Sprays Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Inhalation and Nasal Sprays Generic Drugs Revenue
3.4 Global Inhalation and Nasal Sprays Generic Drugs Market Concentration Ratio
3.4.1 Global Inhalation and Nasal Sprays Generic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inhalation and Nasal Sprays Generic Drugs Revenue in 2020
3.5 Inhalation and Nasal Sprays Generic Drugs Key Players Head office and Area Served
3.6 Key Players Inhalation and Nasal Sprays Generic Drugs Product Solution and Service
3.7 Date of Enter into Inhalation and Nasal Sprays Generic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inhalation and Nasal Sprays Generic Drugs Breakdown Data by Type
4.1 Global Inhalation and Nasal Sprays Generic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Inhalation and Nasal Sprays Generic Drugs Forecasted Market Size by Type (2022-2027)
5 Inhalation and Nasal Sprays Generic Drugs Breakdown Data by Application
5.1 Global Inhalation and Nasal Sprays Generic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Inhalation and Nasal Sprays Generic Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Inhalation and Nasal Sprays Generic Drugs Market Size (2016-2027)
6.2 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Type
6.2.1 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021)
6.2.2 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027)
6.2.3 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2027)
6.3 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Application
6.3.1 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021)
6.3.2 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027)
6.3.3 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2027)
6.4 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Country
6.4.1 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2016-2021)
6.4.2 North America Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Inhalation and Nasal Sprays Generic Drugs Market Size (2016-2027)
7.2 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Type
7.2.1 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2027)
7.3 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Application
7.3.1 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2027)
7.4 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Country
7.4.1 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Type
8.2.1 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Application
8.3.1 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Region
8.4.1 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size (2016-2027)
9.2 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Type
9.2.1 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2027)
9.3 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Application
9.3.1 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2027)
9.4 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Country
9.4.1 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Type
10.2.1 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Application
10.3.1 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Country
10.4.1 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Inhalation and Nasal Sprays Generic Drugs Introduction
11.1.4 Allergan Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Beximco Pharmaceuticals Ltd
11.2.1 Beximco Pharmaceuticals Ltd Company Details
11.2.2 Beximco Pharmaceuticals Ltd Business Overview
11.2.3 Beximco Pharmaceuticals Ltd Inhalation and Nasal Sprays Generic Drugs Introduction
11.2.4 Beximco Pharmaceuticals Ltd Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.2.5 Beximco Pharmaceuticals Ltd Recent Development
11.3 Cipla Limited
11.3.1 Cipla Limited Company Details
11.3.2 Cipla Limited Business Overview
11.3.3 Cipla Limited Inhalation and Nasal Sprays Generic Drugs Introduction
11.3.4 Cipla Limited Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.3.5 Cipla Limited Recent Development
11.4 Mylan N.V.
11.4.1 Mylan N.V. Company Details
11.4.2 Mylan N.V. Business Overview
11.4.3 Mylan N.V. Inhalation and Nasal Sprays Generic Drugs Introduction
11.4.4 Mylan N.V. Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.4.5 Mylan N.V. Recent Development
11.5 Nephron Pharmaceuticals Corporation
11.5.1 Nephron Pharmaceuticals Corporation Company Details
11.5.2 Nephron Pharmaceuticals Corporation Business Overview
11.5.3 Nephron Pharmaceuticals Corporation Inhalation and Nasal Sprays Generic Drugs Introduction
11.5.4 Nephron Pharmaceuticals Corporation Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.5.5 Nephron Pharmaceuticals Corporation Recent Development
11.6 Sun Pharmaceutical Industries Ltd.
11.6.1 Sun Pharmaceutical Industries Ltd. Company Details
11.6.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.6.3 Sun Pharmaceutical Industries Ltd. Inhalation and Nasal Sprays Generic Drugs Introduction
11.6.4 Sun Pharmaceutical Industries Ltd. Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.6.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Details
11.7.2 Hikma Pharmaceuticals Business Overview
11.7.3 Hikma Pharmaceuticals Inhalation and Nasal Sprays Generic Drugs Introduction
11.7.4 Hikma Pharmaceuticals Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.7.5 Hikma Pharmaceuticals Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Inhalation and Nasal Sprays Generic Drugs Introduction
11.8.4 Novartis Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Perrigo Company
11.9.1 Perrigo Company Company Details
11.9.2 Perrigo Company Business Overview
11.9.3 Perrigo Company Inhalation and Nasal Sprays Generic Drugs Introduction
11.9.4 Perrigo Company Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.9.5 Perrigo Company Recent Development
11.10 Catalent Pharma Solutions
11.10.1 Catalent Pharma Solutions Company Details
11.10.2 Catalent Pharma Solutions Business Overview
11.10.3 Catalent Pharma Solutions Inhalation and Nasal Sprays Generic Drugs Introduction
11.10.4 Catalent Pharma Solutions Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.10.5 Catalent Pharma Solutions Recent Development
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Details
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Inhalation and Nasal Sprays Generic Drugs Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Inhalation and Nasal Sprays Generic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Bronchodilator
Table 4. Key Players of Antihistamine
Table 5. Key Players of Congestive Spray
Table 6. Key Players of Other
Table 7. Global Inhalation and Nasal Sprays Generic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Inhalation and Nasal Sprays Generic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Inhalation and Nasal Sprays Generic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Inhalation and Nasal Sprays Generic Drugs Market Share by Regions (2016-2021)
Table 11. Global Inhalation and Nasal Sprays Generic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Inhalation and Nasal Sprays Generic Drugs Market Share by Regions (2022-2027)
Table 13. Inhalation and Nasal Sprays Generic Drugs Market Trends
Table 14. Inhalation and Nasal Sprays Generic Drugs Market Drivers
Table 15. Inhalation and Nasal Sprays Generic Drugs Market Challenges
Table 16. Inhalation and Nasal Sprays Generic Drugs Market Restraints
Table 17. Global Inhalation and Nasal Sprays Generic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Inhalation and Nasal Sprays Generic Drugs Market Share by Players (2016-2021)
Table 19. Global Top Inhalation and Nasal Sprays Generic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhalation and Nasal Sprays Generic Drugs as of 2020)
Table 20. Ranking of Global Top Inhalation and Nasal Sprays Generic Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Inhalation and Nasal Sprays Generic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Inhalation and Nasal Sprays Generic Drugs Product Solution and Service
Table 24. Date of Enter into Inhalation and Nasal Sprays Generic Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Inhalation and Nasal Sprays Generic Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Inhalation and Nasal Sprays Generic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Inhalation and Nasal Sprays Generic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Inhalation and Nasal Sprays Generic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Inhalation and Nasal Sprays Generic Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Inhalation and Nasal Sprays Generic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Inhalation and Nasal Sprays Generic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Allergan Company Details
Table 65. Allergan Business Overview
Table 66. Allergan Inhalation and Nasal Sprays Generic Drugs Product
Table 67. Allergan Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 68. Allergan Recent Development
Table 69. Beximco Pharmaceuticals Ltd Company Details
Table 70. Beximco Pharmaceuticals Ltd Business Overview
Table 71. Beximco Pharmaceuticals Ltd Inhalation and Nasal Sprays Generic Drugs Product
Table 72. Beximco Pharmaceuticals Ltd Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 73. Beximco Pharmaceuticals Ltd Recent Development
Table 74. Cipla Limited Company Details
Table 75. Cipla Limited Business Overview
Table 76. Cipla Limited Inhalation and Nasal Sprays Generic Drugs Product
Table 77. Cipla Limited Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 78. Cipla Limited Recent Development
Table 79. Mylan N.V. Company Details
Table 80. Mylan N.V. Business Overview
Table 81. Mylan N.V. Inhalation and Nasal Sprays Generic Drugs Product
Table 82. Mylan N.V. Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 83. Mylan N.V. Recent Development
Table 84. Nephron Pharmaceuticals Corporation Company Details
Table 85. Nephron Pharmaceuticals Corporation Business Overview
Table 86. Nephron Pharmaceuticals Corporation Inhalation and Nasal Sprays Generic Drugs Product
Table 87. Nephron Pharmaceuticals Corporation Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 88. Nephron Pharmaceuticals Corporation Recent Development
Table 89. Sun Pharmaceutical Industries Ltd. Company Details
Table 90. Sun Pharmaceutical Industries Ltd. Business Overview
Table 91. Sun Pharmaceutical Industries Ltd. Inhalation and Nasal Sprays Generic Drugs Product
Table 92. Sun Pharmaceutical Industries Ltd. Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 93. Sun Pharmaceutical Industries Ltd. Recent Development
Table 94. Hikma Pharmaceuticals Company Details
Table 95. Hikma Pharmaceuticals Business Overview
Table 96. Hikma Pharmaceuticals Inhalation and Nasal Sprays Generic Drugs Product
Table 97. Hikma Pharmaceuticals Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 98. Hikma Pharmaceuticals Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 102. Novartis Recent Development
Table 103. Perrigo Company Company Details
Table 104. Perrigo Company Business Overview
Table 105. Perrigo Company Inhalation and Nasal Sprays Generic Drugs Product
Table 106. Perrigo Company Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 107. Perrigo Company Recent Development
Table 108. Catalent Pharma Solutions Company Details
Table 109. Catalent Pharma Solutions Business Overview
Table 110. Catalent Pharma Solutions Inhalation and Nasal Sprays Generic Drugs Product
Table 111. Catalent Pharma Solutions Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 112. Catalent Pharma Solutions Recent Development
Table 113. Teva Pharmaceutical Industries Ltd. Company Details
Table 114. Teva Pharmaceutical Industries Ltd. Business Overview
Table 115. Teva Pharmaceutical Industries Ltd. Inhalation and Nasal Sprays Generic Drugs Product
Table 116. Teva Pharmaceutical Industries Ltd. Revenue in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021) & (US$ Million)
Table 117. Teva Pharmaceutical Industries Ltd. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inhalation and Nasal Sprays Generic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Bronchodilator Features
Figure 4. Antihistamine Features
Figure 5. Congestive Spray Features
Figure 6. Other Features
Figure 7. Global Inhalation and Nasal Sprays Generic Drugs Market Share by Application: 2020 VS 2027
Figure 8. Asthma Case Studies
Figure 9. Chronic Obstructive Pulmonary Disease (COPD) Case Studies
Figure 10. Allergic Rhinitis Case Studies
Figure 11. Other Case Studies
Figure 12. Inhalation and Nasal Sprays Generic Drugs Report Years Considered
Figure 13. Global Inhalation and Nasal Sprays Generic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Inhalation and Nasal Sprays Generic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Inhalation and Nasal Sprays Generic Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Inhalation and Nasal Sprays Generic Drugs Market Share by Regions (2022-2027)
Figure 17. Global Inhalation and Nasal Sprays Generic Drugs Market Share by Players in 2020
Figure 18. Global Top Inhalation and Nasal Sprays Generic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhalation and Nasal Sprays Generic Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Inhalation and Nasal Sprays Generic Drugs Revenue in 2020
Figure 20. Global Inhalation and Nasal Sprays Generic Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Inhalation and Nasal Sprays Generic Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Inhalation and Nasal Sprays Generic Drugs Market Share by Type (2016-2027)
Figure 24. North America Inhalation and Nasal Sprays Generic Drugs Market Share by Application (2016-2027)
Figure 25. North America Inhalation and Nasal Sprays Generic Drugs Market Share by Country (2016-2027)
Figure 26. United States Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Inhalation and Nasal Sprays Generic Drugs Market Share by Type (2016-2027)
Figure 30. Europe Inhalation and Nasal Sprays Generic Drugs Market Share by Application (2016-2027)
Figure 31. Europe Inhalation and Nasal Sprays Generic Drugs Market Share by Country (2016-2027)
Figure 32. Germany Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Inhalation and Nasal Sprays Generic Drugs Market Share by Region (2016-2027)
Figure 42. China Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Inhalation and Nasal Sprays Generic Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Inhalation and Nasal Sprays Generic Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Inhalation and Nasal Sprays Generic Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Inhalation and Nasal Sprays Generic Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Inhalation and Nasal Sprays Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Allergan Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 62. Beximco Pharmaceuticals Ltd Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 63. Cipla Limited Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 64. Mylan N.V. Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 65. Nephron Pharmaceuticals Corporation Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 66. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 67. Hikma Pharmaceuticals Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 69. Perrigo Company Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 70. Catalent Pharma Solutions Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 71. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Inhalation and Nasal Sprays Generic Drugs Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の慢性閉塞性肺疾患（COPD）治療薬市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a chronic bronchitis and/or emphysema characterized by airflow obstruction, which can further develop into a common chronic disease of cor pulmona and respiratory failure.It is related to the abnormal inflammatory reaction of harmful gases and harmful …- 世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disorder (COPD) Market The global Chronic Obstructive Pulmonary Disorder (COPD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy…
- 世界のスプレーベース吸入剤市場 2021：企業別、地域別、種類・用途別 The Inhalation Spray-Based Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…
- 世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Th…